Best Radiotherapy for lung cancer doctors in Israel: TOP 4 doctors

Head of the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – Prof. Merimsky specializes in complex lung cancer cases.

• Over 41 years of experience of experience in oncology
• Fellowship in soft tissue and bone sarcoma at Institut Gustave Roussy
• Member of ESMO Sarcoma group faculty
• Published extensively on cancer treatment outcomes

Dr. Ari Raphael is a leading expert in lung cancer radiotherapy, with a strong focus on advanced genomic profiling and clinical trials.

• Senior lecturer and medical oncologist at Sourasky Medical Center
• Leader of the Israeli National Genomic Medicine Initiative project
• Primary investigator for innovative studies on NSCLC immunotherapy
• Member of European and international thoracic oncology societies
• Outstanding teacher award from Tel-Aviv University's medical faculty

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.